Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pain and multiple sclerosis: pathophysiology and treatment.
[Chronically Ill and Unemployed? A Review on Vocational Status in Multiple Sclerosis].
Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis.
Clinical and paraclinical findings in natalizumab-associated infratentorial progressive multifocal leukoencephalopathy patients.
Neurological disability and its association with walking impairment in multiple sclerosis: brief review.
Incidence of therapy-related acute leukaemia in mitoxantrone-treated multiple sclerosis patients in Germany.
Are there Epstein-Barr virus seronegative patients with multiple sclerosis?
A Double-masked, Placebo-controlled Study With Open Label Period to Evaluate MEDI-551 in Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
Evaluating medically at-risk drivers: a survey of assessment practices in Canada.
Galectin-1 deactivates classically activated microglia and protects from inflammation-induced neurodegeneration.
Coping Strategies in Multiple Sclerosis Patients with Frontal Cognitive Disorders.
Multiple sclerosis risk loci and disease severity in 7,125 individuals from 10 studies.
Structure of the first sphingosine 1-phosphate receptor.
Interferon Beta Use and Disability Prevention in Relapsing-Remitting Multiple Sclerosis.
Distinct serum cytokine profiles in neuromyelitis optica and multiple sclerosis.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Multiple sclerosis relapses and depression.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
The multiple sclerosis relapse experience: patient-reported outcomes from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
Surgical management of malignant cerebral edema secondary to immune reconstitution inflammatory syndrome from natalizumab-associated progressive multifocal encephalopathy.
Regression-Based Norms Improve the Sensitivity of the National MS Society Consensus Neuropsychological Battery for Pediatric Multiple Sclerosis (NBPMS).
Minocycline attenuates experimental colitis in mice by blocking expression of inducible nitric oxide synthase and matrix metalloproteinases.
The VZV/IE63-specific T cell response prevents herpes zoster in fingolimod-treated patients.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Back on the scent: the olfactory system in CNS demyelinating diseases.
Pages
« first
‹ previous
…
157
158
159
160
161
162
163
164
165
…
next ›
last »